Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate

Farideh Shiehzadeh ^1,2,3 , Mohsen Tafaghodi ³ * , Majid Laal-Dehghani ^1,2, Faezeh Mashhoori ^1,2, Bibi Sedigheh Fazly Bazzaz ^4,5 , Mohsen Imenshahidi ⁶

Cited by CrossRef: 12

1- Yaqoubi S, Chan H, Nokhodchi A, Dastmalchi S, Alizadeh A, Barzegar-Jalali M, Adibkia K, Hamishehkar H. A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols. International Journal of Pharmaceutics. 2021;602:120568 [Crossref]

2- Rohde F, Walther M, Wächter J, Knetzger N, Lotz C, Windbergs M. In-situ tear fluid dissolving nanofibers enable prolonged viscosity-enhanced dual drug delivery to the eye. International Journal of Pharmaceutics. 2022;616:121513 [Crossref]

3- Poudel I, Annaji M, Zhang C, Panizzi P, Arnold R, Kaddoumi A, Amin R, Lee S, Shamsaei N, Babu R. Gentamicin Eluting 3D-Printed Implants for Preventing Post-Surgical Infections in Bone Fractures. Mol Pharmaceutics. 2023;20(8):4236 [Crossref]

4- Negi A, Nimbkar S, Moses J. Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches. Pharmaceutics. 2023;15(12):2706 [Crossref]

5- Huang Y, Tang H, Meng X, Zhao Z, Liu Y, Liu D, Chen B, Zou Z. Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A. Pharmaceutics. 2023;15(9):2204 [Crossref]

6- Zhao Z, Wang G, Huang Z, Huang Y, Chen H, Pan X, Zhang X. Dry Powder Inhalers Based on Chitosan-Mannitol Binary Carriers: Effect of the Powder Properties on the Aerosolization Performance. AAPS PharmSciTech. 2022;23(5) [Crossref]

7- Lagreca E, Onesto V, Di Natale C, La Manna S, Netti P, Vecchione R. Recent advances in the formulation of PLGA microparticles for controlled drug delivery. Prog Biomater. 2020;9(4):153 [Crossref]

8- Duong T, López-Iglesias C, Szewczyk P, Stachewicz U, Barros J, Alvarez-Lorenzo C, Alnaief M, García-González C. A Pathway From Porous Particle Technology Toward Tailoring Aerogels for Pulmonary Drug Administration. Front Bioeng Biotechnol. 2021;9 [Crossref]

9- Karimi M, Kamali H, Mohammadi M, Tafaghodi M. Evaluation of various techniques for production of inhalable dry powders for pulmonary delivery of peptide and protein. Journal of Drug Delivery Science and Technology. 2022;69:103186 [Crossref]

10- Zhu M, Zhang D, Zhang L, Zhao L, Xu L, Wang B, Zhang X, Chen J, Bei Z, Wang H, Zhou D, Yang W, Song Y. Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model. Pharmaceutics. 2022;14(12):2646 [Crossref]

11- Shiehzadeh F, Hadizadeh F, Mohammadpour A, Aryan E, Gholami L, Tafaghodi M. Streptomycin sulfate dry powder inhalers for the new tuberculosis treatment schedule. Journal of Drug Delivery Science and Technology. 2019;52:957 [Crossref]

12- Gunduz O, Ulag S. Gentamicin and fluconazole loaded electrospun polymethylmethacrylate (PMMA) fibers as a novel platform for the treatment of corneal keratitis. International Journal of Polymeric Materials and Polymeric Biomaterials. 2023;72(12):995 [Crossref]